Skip to main content
Caplight Logo









Pan.bio

Pan.bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://pan.bio/

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Pan.bio operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. It was founded in 2022.

Pan.bio is a healthcare technology company that provides an AI-powered, end-to-end genomics platform for bioinformatics workflows, variant interpretation, and patient cohort data analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Healthcare Analytics, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Marketplace Commission, Freemium, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Pan.bio Comparables

Compare Pan.bio with similar companies based on industry and business-model similarity.

Pan.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rosalind
79%
Ploid AI
77%
Basepair Inc
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Pan.bio Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Pan.bio. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ahmad Jadallah

Chief Executive Officer

Executive Team

Basel Abu-Jamous

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2026

    Grew 38% QoQ, from 13 to 18 employees.

  • Jul 23, 2026

    Grew 25% QoQ, from 12 to 15 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Pan.bio Filings

Explore SEC and related filing metadata, where available.

Pan.bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Pan.bio's valuation, stock price, and market status.

Is Pan.bio a public or private company?

Pan.bio is a private company.

What is the current stock price of Pan.bio?

Pan.bio is a private company, so its shares have no public market price. Caplight tracks Pan.bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Pan.bio worth (valuation)?

Valuation information for Pan.bio is not publicly available.

Can I buy Pan.bio stock?

Pan.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Pan.bio's last funding round?

Funding round information for Pan.bio is not publicly available.

Who are the main investors in Pan.bio?

Investor information for Pan.bio is not publicly disclosed.

Will Pan.bio IPO soon?

No public IPO plans have been announced for Pan.bio.

How can I track Pan.bio secondary market activity?

Caplight tracks bids, offers, and trades in Pan.bio's shares on secondary markets.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range17
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?